These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14743190)

  • 21. Extracorporeal photopheresis: clinical use so far.
    Sanford KW; Balogun RA
    J Clin Apher; 2012; 27(3):126-31. PubMed ID: 22467383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
    Perseghin P; Galimberti S; Balduzzi A; Bonanomi S; Baldini V; Rovelli A; Dassi M; Rambaldi A; Castagna L; Corti P; Pogliani EM; Uderzo C
    Ther Apher Dial; 2007 Apr; 11(2):85-93. PubMed ID: 17381528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants.
    Gyger M; Rosenberg A; Shamy A; Hercz A; Caplan S; Sebag IA; Brisson ML; Roy DC
    Bone Marrow Transplant; 2005 Jan; 35(2):201-3. PubMed ID: 15558044
    [No Abstract]   [Full Text] [Related]  

  • 27. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
    Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):195-203. PubMed ID: 14993885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
    Greinix HT; Knobler RM; Worel N; Schneider B; Schneeberger A; Hoecker P; Mitterbauer M; Rabitsch W; Schulenburg A; Kalhs P
    Haematologica; 2006 Mar; 91(3):405-8. PubMed ID: 16531267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
    Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
    Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term follow-up of lymphocyte populations and cellular cytokine production in patients with chronic graft-versus-host disease treated with extracorporeal photopheresis.
    Silva MG; Ferreira Neto L; Guimarães A; Machado A; Parreira A; Abecasis M
    Haematologica; 2005 Apr; 90(4):565-7. PubMed ID: 15820961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Jiang Q; Chen H; Xu L; Liu D; Chen Y; Han W; Zhang Y; Liu K; Lu D
    Bone Marrow Transplant; 2005 Aug; 36(4):343-8. PubMed ID: 15968295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient.
    Dohm A; Hasenkamp J; Bertsch HP; Maas JH; Truemper L; Wulf G
    Bone Marrow Transplant; 2011 Jun; 46(6):899-900. PubMed ID: 20729923
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photopheresis long after the initiation of chronic graft versus host in a child.
    Uygun V; Daloglu H; Karasu G; Yeşilipek A
    Transfus Apher Sci; 2014 Oct; 51(2):172-4. PubMed ID: 25217990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
    Spisek R; Gasova Z; Bartunkova J
    Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythema multiforme-like presentation of chronic graft versus host disease.
    Doherty C; Ulitsky O; Petronic-Rosic V
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S127-8. PubMed ID: 19119127
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of extracorporeal photochemotherapy in treating refractory chronic graft-versus-host disease.
    Biagi E; Perseghin P; Buscemi F; Dassi M; Rovelli A; Balduzzi A
    Haematologica; 2000 Mar; 85(3):329-30. PubMed ID: 10702832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.